newsfilter
← Latest News
GlobeNewswire·

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver Meeting

Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity IMC-I109V is a bispecific T cell receptor targeting a peptide derived from HBsAg that is presented by HLA-A*02:01 on